We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRI icon
1276
Primerica
PRI
$9.56B
– –
-801
Closed -$217K
PRLB icon
1277
Protolabs
PRLB
$2.19B
– –
-16,258
Closed -$636K
PSFE icon
1278
Paysafe
PSFE
$352M
– –
-11,620
Closed -$199K
PTCT icon
1279
PTC Therapeutics
PTCT
$6.05B
– –
-9,132
Closed -$412K
PUBM icon
1280
PubMatic
PUBM
$784M
– –
-14,339
Closed -$211K
QGEN icon
1281
Qiagen
QGEN
$8.86B
– –
-41,305
Closed -$1.89M
QURE icon
1282
uniQure
QURE
$3.13B
– –
-123,210
Closed -$2.18M
R icon
1283
Ryder
R
$10.1B
– –
-3,153
Closed -$495K
RARE icon
1284
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-39,694
Closed -$1.67M
RBA icon
1285
RB Global
RBA
$16B
– –
-10,645
Closed -$960K
RCL icon
1286
Royal Caribbean
RCL
$82.4B
– –
-3,331
Closed -$768K
REGN icon
1287
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-6,882
Closed -$4.9M
REZI icon
1288
Resideo Technologies
REZI
$3.83B
– –
-44,733
Closed -$1.03M
RGR icon
1289
Sturm, Ruger & Co
RGR
$601M
– –
-11,340
Closed -$401K
RHP icon
1290
Ryman Hospitality Properties
RHP
$7.91B
– –
-5,614
Closed -$586K
RKLB icon
1291
Rocket Lab Corp
RKLB
$52B
– –
-25,192
Closed -$642K
RMBS icon
1292
Rambus
RMBS
$11B
– –
-25,871
Closed -$1.37M
ROCK icon
1293
Gibraltar Industries
ROCK
$1.47B
– –
-9,147
Closed -$539K
ROKU icon
1294
Roku
ROKU
$22.5B
– –
-7,786
Closed -$579K
ROP icon
1295
Roper Technologies
ROP
$39B
– –
-14,101
Closed -$7.33M
RSI icon
1296
Rush Street Interactive
RSI
$2.82B
– –
-28,522
Closed -$391K
RVLV icon
1297
Revolve Group
RVLV
$1.69B
– –
-22,852
Closed -$765K
SA
1298
Seabridge Gold
SA
$3.53B
– –
-47,023
Closed -$537K
SAFT icon
1299
Safety Insurance
SAFT
$1.52B
– –
-2,667
Closed -$220K
SAH icon
1300
Sonic Automotive
SAH
$2.56B
– –
-12,449
Closed -$789K
50 51
52
53 54

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.